Questcor Pharmaceuticals (QSC) Reports Q4 Earnings, Approves Stock Buyback Plan
Tweet Send to a Friend
Questcor Pharmaceuticals, Inc. (AMEX: QSC) reports Q4 EPS of $0.45 compared to a $0.06 loss for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
